Vendor notebook: New AI tools to cut billing burdens, improve testing and more
Femtech developer Aspira Women’s Health signs with Dana Farber to license a biomarker-based ovarian cancer diagnostic, a Madrona Venture Labs spinout adds GPT-enabled virtual agents to billing automation and Dave, an LLM oncology tool, is born.
Femtech developer Aspira Women’s Health signs with Dana Farber to license a biomarker-based ovarian cancer diagnostic, a Madrona Venture Labs spinout adds GPT-enabled virtual agents to billing automation and Dave, an LLM oncology tool, is born.
Go to Source
2023-05-12 20:21
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
